nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Fluorouracil—breast cancer	0.141	0.347	CbGbCtD
Ganciclovir—SLC22A7—Docetaxel—breast cancer	0.107	0.265	CbGbCtD
Ganciclovir—SLC22A7—Methotrexate—breast cancer	0.0776	0.191	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—breast cancer	0.0474	0.117	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—breast cancer	0.033	0.0813	CbGbCtD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000527	0.00575	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000506	0.00552	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000506	0.00552	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000501	0.00546	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000499	0.00544	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000462	0.00504	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000456	0.00498	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000454	0.00495	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000439	0.00479	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000439	0.00479	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000422	0.00461	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000422	0.00461	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000421	0.00459	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000419	0.00457	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000384	0.00418	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—KCNN4—breast cancer	0.000381	0.00415	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000378	0.00412	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000369	0.00403	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000369	0.00403	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000359	0.00391	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000351	0.00383	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.00035	0.00382	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000335	0.00365	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000328	0.00358	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000328	0.00358	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.00032	0.00349	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000318	0.00347	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000308	0.00336	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000308	0.00336	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000306	0.00334	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000306	0.00334	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000281	0.00307	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000273	0.00298	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000272	0.00297	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000265	0.00289	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000257	0.0028	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000257	0.0028	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—COX11—breast cancer	0.000254	0.00276	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000254	0.00276	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000249	0.00271	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—KCNH1—breast cancer	0.000245	0.00267	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000239	0.00261	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000239	0.00261	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—TP53—breast cancer	0.000236	0.00258	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000235	0.00256	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000232	0.00253	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000227	0.00248	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000223	0.00243	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000223	0.00243	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000215	0.00234	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000215	0.00234	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—COX11—breast cancer	0.000213	0.00232	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000213	0.00232	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000206	0.00225	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000195	0.00213	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000192	0.0021	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000191	0.00208	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000188	0.00205	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000188	0.00205	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000182	0.00199	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000182	0.00199	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—COX11—breast cancer	0.000178	0.00194	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000178	0.00194	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000176	0.00192	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000176	0.00192	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000167	0.00182	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000167	0.00182	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000163	0.00178	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000163	0.00177	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000162	0.00176	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00016	0.00174	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000157	0.00171	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000157	0.00171	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000153	0.00167	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000148	0.00161	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000148	0.00161	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—ACHE—breast cancer	0.000143	0.00155	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000139	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000138	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000138	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000137	0.0015	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000135	0.00147	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000128	0.0014	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000126	0.00138	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—BCHE—breast cancer	0.000124	0.00135	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000124	0.00135	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000124	0.00135	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000123	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000122	0.00133	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000122	0.00133	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000117	0.00127	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000116	0.00126	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000115	0.00125	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000113	0.00123	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ACHE—breast cancer	0.000109	0.00119	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000105	0.00114	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—TFRC—breast cancer	0.000101	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	9.94e-05	0.00108	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—COMT—breast cancer	9.93e-05	0.00108	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	9.75e-05	0.00106	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—NCOA2—breast cancer	9.72e-05	0.00106	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A2—breast cancer	9.72e-05	0.00106	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	9.6e-05	0.00105	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ATP7B—breast cancer	9.58e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG2—breast cancer	9.52e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—BCHE—breast cancer	9.51e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.27e-05	0.00101	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A1—breast cancer	8.95e-05	0.000976	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC1—breast cancer	8.91e-05	0.000971	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—ALB—breast cancer	8.7e-05	0.000949	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—TFRC—breast cancer	8.48e-05	0.000925	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—NCOA1—breast cancer	8.19e-05	0.000893	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA2—breast cancer	8.17e-05	0.00089	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	8.11e-05	0.000884	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PLG—breast cancer	7.98e-05	0.00087	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	7.94e-05	0.000866	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SYNJ2—breast cancer	7.81e-05	0.000852	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	7.79e-05	0.00085	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—COMT—breast cancer	7.61e-05	0.000829	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—TUBB3—breast cancer	7.57e-05	0.000826	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.52e-05	0.00082	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—HMOX1—breast cancer	7.36e-05	0.000803	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	7.31e-05	0.000797	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NDUFS3—breast cancer	7.26e-05	0.000792	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	7.08e-05	0.000772	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCB1—breast cancer	7.07e-05	0.000771	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	6.88e-05	0.00075	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CHST9—breast cancer	6.83e-05	0.000745	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	6.82e-05	0.000743	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	6.71e-05	0.000731	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.5e-05	0.000709	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—COX11—breast cancer	6.47e-05	0.000706	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—BRAF—breast cancer	6.34e-05	0.000691	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	6.3e-05	0.000687	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.28e-05	0.000685	CbGpPWpGaD
Ganciclovir—Hepatitis—Doxorubicin—breast cancer	6.27e-05	0.000125	CcSEcCtD
Ganciclovir—Insomnia—Capecitabine—breast cancer	6.25e-05	0.000124	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—breast cancer	6.24e-05	0.000124	CcSEcCtD
Ganciclovir—Rash—Fluorouracil—breast cancer	6.24e-05	0.000124	CcSEcCtD
Ganciclovir—Dermatitis—Fluorouracil—breast cancer	6.23e-05	0.000124	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—breast cancer	6.22e-05	0.000124	CcSEcCtD
Ganciclovir—Paraesthesia—Capecitabine—breast cancer	6.21e-05	0.000124	CcSEcCtD
Ganciclovir—Decreased appetite—Docetaxel—breast cancer	6.21e-05	0.000124	CcSEcCtD
Ganciclovir—Hypersensitivity—Paclitaxel—breast cancer	6.2e-05	0.000124	CcSEcCtD
Ganciclovir—Headache—Fluorouracil—breast cancer	6.2e-05	0.000123	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—breast cancer	6.19e-05	0.000123	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	6.19e-05	0.000675	CbGpPWpGaD
Ganciclovir—Oedema peripheral—Doxorubicin—breast cancer	6.18e-05	0.000123	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCG2—breast cancer	6.17e-05	0.000673	CbGpPWpGaD
Ganciclovir—Dysgeusia—Methotrexate—breast cancer	6.17e-05	0.000123	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Docetaxel—breast cancer	6.16e-05	0.000123	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—breast cancer	6.16e-05	0.000123	CcSEcCtD
Ganciclovir—Dyspnoea—Capecitabine—breast cancer	6.16e-05	0.000123	CcSEcCtD
Ganciclovir—Fatigue—Docetaxel—breast cancer	6.15e-05	0.000123	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—breast cancer	6.15e-05	0.000122	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—breast cancer	6.15e-05	0.000122	CcSEcCtD
Ganciclovir—Nausea—Mitoxantrone—breast cancer	6.13e-05	0.000122	CcSEcCtD
Ganciclovir—Nausea—Irinotecan—breast cancer	6.13e-05	0.000122	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—breast cancer	6.11e-05	0.000122	CcSEcCtD
Ganciclovir—Constipation—Docetaxel—breast cancer	6.1e-05	0.000122	CcSEcCtD
Ganciclovir—Pain—Docetaxel—breast cancer	6.1e-05	0.000122	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	6.1e-05	0.000666	CbGpPWpGaD
Ganciclovir—Back pain—Methotrexate—breast cancer	6.1e-05	0.000121	CcSEcCtD
Ganciclovir—Dyspepsia—Capecitabine—breast cancer	6.08e-05	0.000121	CcSEcCtD
Ganciclovir—Chills—Epirubicin—breast cancer	6.08e-05	0.000121	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—breast cancer	6.05e-05	0.000121	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—breast cancer	6.04e-05	0.00012	CcSEcCtD
Ganciclovir—Asthenia—Paclitaxel—breast cancer	6.04e-05	0.00012	CcSEcCtD
Ganciclovir—Decreased appetite—Capecitabine—breast cancer	6.01e-05	0.00012	CcSEcCtD
Ganciclovir—Alopecia—Epirubicin—breast cancer	5.99e-05	0.000119	CcSEcCtD
Ganciclovir—Nausea—Gemcitabine—breast cancer	5.97e-05	0.000119	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Capecitabine—breast cancer	5.97e-05	0.000119	CcSEcCtD
Ganciclovir—Fatigue—Capecitabine—breast cancer	5.96e-05	0.000119	CcSEcCtD
Ganciclovir—Pruritus—Paclitaxel—breast cancer	5.96e-05	0.000119	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—breast cancer	5.94e-05	0.000118	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	5.94e-05	0.000648	CbGpPWpGaD
Ganciclovir—Mental disorder—Epirubicin—breast cancer	5.94e-05	0.000118	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—breast cancer	5.93e-05	0.000118	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—CDA—breast cancer	5.92e-05	0.000646	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SHMT1—breast cancer	5.92e-05	0.000646	CbGpPWpGaD
Ganciclovir—Constipation—Capecitabine—breast cancer	5.91e-05	0.000118	CcSEcCtD
Ganciclovir—Pain—Capecitabine—breast cancer	5.91e-05	0.000118	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—breast cancer	5.9e-05	0.000117	CcSEcCtD
Ganciclovir—Feeling abnormal—Docetaxel—breast cancer	5.88e-05	0.000117	CcSEcCtD
Ganciclovir—Nausea—Fluorouracil—breast cancer	5.87e-05	0.000117	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—breast cancer	5.85e-05	0.000116	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—breast cancer	5.85e-05	0.000116	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Docetaxel—breast cancer	5.84e-05	0.000116	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—breast cancer	5.83e-05	0.000116	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—breast cancer	5.81e-05	0.000116	CcSEcCtD
Ganciclovir—Tension—Epirubicin—breast cancer	5.79e-05	0.000115	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—breast cancer	5.78e-05	0.000115	CcSEcCtD
Ganciclovir—Diarrhoea—Paclitaxel—breast cancer	5.76e-05	0.000115	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	5.74e-05	0.000626	CbGpPWpGaD
Ganciclovir—Nervousness—Epirubicin—breast cancer	5.73e-05	0.000114	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—breast cancer	5.71e-05	0.000114	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—SLCO1B1—breast cancer	5.7e-05	0.000621	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC2A5—breast cancer	5.7e-05	0.000621	CbGpPWpGaD
Ganciclovir—Feeling abnormal—Capecitabine—breast cancer	5.7e-05	0.000113	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—breast cancer	5.69e-05	0.000113	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—breast cancer	5.68e-05	0.000113	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—breast cancer	5.67e-05	0.000113	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—breast cancer	5.66e-05	0.000113	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Capecitabine—breast cancer	5.65e-05	0.000113	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—breast cancer	5.65e-05	0.000113	CcSEcCtD
Ganciclovir—Abdominal pain—Docetaxel—breast cancer	5.64e-05	0.000112	CcSEcCtD
Ganciclovir—Body temperature increased—Docetaxel—breast cancer	5.64e-05	0.000112	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—breast cancer	5.64e-05	0.000112	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—breast cancer	5.63e-05	0.000112	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—breast cancer	5.6e-05	0.000112	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	5.6e-05	0.00061	CbGpPWpGaD
Ganciclovir—Dizziness—Paclitaxel—breast cancer	5.57e-05	0.000111	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—breast cancer	5.56e-05	0.000111	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—breast cancer	5.54e-05	0.00011	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—APRT—breast cancer	5.5e-05	0.0006	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—TFRC—breast cancer	5.5e-05	0.0006	CbGpPWpGaD
Ganciclovir—Cough—Methotrexate—breast cancer	5.5e-05	0.00011	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—breast cancer	5.49e-05	0.000109	CcSEcCtD
Ganciclovir—Urticaria—Capecitabine—breast cancer	5.49e-05	0.000109	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—breast cancer	5.47e-05	0.000109	CcSEcCtD
Ganciclovir—Abdominal pain—Capecitabine—breast cancer	5.46e-05	0.000109	CcSEcCtD
Ganciclovir—Body temperature increased—Capecitabine—breast cancer	5.46e-05	0.000109	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—breast cancer	5.46e-05	0.000109	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—breast cancer	5.46e-05	0.000109	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—breast cancer	5.45e-05	0.000109	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—breast cancer	5.42e-05	0.000108	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—breast cancer	5.38e-05	0.000107	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—breast cancer	5.37e-05	0.000107	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—breast cancer	5.37e-05	0.000107	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—breast cancer	5.37e-05	0.000107	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—breast cancer	5.36e-05	0.000107	CcSEcCtD
Ganciclovir—Vomiting—Paclitaxel—breast cancer	5.35e-05	0.000107	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—breast cancer	5.35e-05	0.000106	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.33e-05	0.000106	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—breast cancer	5.32e-05	0.000106	CcSEcCtD
Ganciclovir—Rash—Paclitaxel—breast cancer	5.31e-05	0.000106	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—MDM2—breast cancer	5.31e-05	0.000579	CbGpPWpGaD
Ganciclovir—Dermatitis—Paclitaxel—breast cancer	5.31e-05	0.000106	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—breast cancer	5.3e-05	0.000106	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—breast cancer	5.3e-05	0.000106	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—breast cancer	5.3e-05	0.000106	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—NCOA2—breast cancer	5.3e-05	0.000578	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—RAF1—breast cancer	5.29e-05	0.000577	CbGpPWpGaD
Ganciclovir—Leukopenia—Epirubicin—breast cancer	5.28e-05	0.000105	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—breast cancer	5.28e-05	0.000105	CcSEcCtD
Ganciclovir—Headache—Paclitaxel—breast cancer	5.28e-05	0.000105	CcSEcCtD
Ganciclovir—Hypersensitivity—Docetaxel—breast cancer	5.26e-05	0.000105	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—breast cancer	5.25e-05	0.000104	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—breast cancer	5.19e-05	0.000103	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ESRRA—breast cancer	5.18e-05	0.000564	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ANGPTL4—breast cancer	5.18e-05	0.000564	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	5.17e-05	0.000563	CbGpPWpGaD
Ganciclovir—Cough—Epirubicin—breast cancer	5.15e-05	0.000103	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—breast cancer	5.14e-05	0.000102	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—breast cancer	5.14e-05	0.000102	CcSEcCtD
Ganciclovir—Asthenia—Docetaxel—breast cancer	5.12e-05	0.000102	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—breast cancer	5.11e-05	0.000102	CcSEcCtD
Ganciclovir—Infection—Methotrexate—breast cancer	5.11e-05	0.000102	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—breast cancer	5.09e-05	0.000101	CcSEcCtD
Ganciclovir—Hypersensitivity—Capecitabine—breast cancer	5.09e-05	0.000101	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—breast cancer	5.06e-05	0.000101	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	5.05e-05	0.000551	CbGpPWpGaD
Ganciclovir—Pruritus—Docetaxel—breast cancer	5.05e-05	0.000101	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—breast cancer	5.05e-05	0.0001	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—breast cancer	5.04e-05	0.0001	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—breast cancer	5.02e-05	0.0001	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—breast cancer	5.02e-05	0.0001	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—breast cancer	5.02e-05	0.0001	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—breast cancer	5.02e-05	9.99e-05	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—breast cancer	5.01e-05	9.97e-05	CcSEcCtD
Ganciclovir—Nausea—Paclitaxel—breast cancer	5e-05	9.96e-05	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—breast cancer	5e-05	9.95e-05	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.99e-05	9.93e-05	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—breast cancer	4.97e-05	9.9e-05	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—breast cancer	4.96e-05	9.88e-05	CcSEcCtD
Ganciclovir—Asthenia—Capecitabine—breast cancer	4.96e-05	9.87e-05	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	4.96e-05	0.000541	CbGpPWpGaD
Ganciclovir—Malaise—Doxorubicin—breast cancer	4.92e-05	9.8e-05	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—breast cancer	4.91e-05	9.78e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—HADHB—breast cancer	4.91e-05	0.000535	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPI—breast cancer	4.91e-05	0.000535	CbGpPWpGaD
Ganciclovir—Vertigo—Doxorubicin—breast cancer	4.9e-05	9.76e-05	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—breast cancer	4.9e-05	9.76e-05	CcSEcCtD
Ganciclovir—Pruritus—Capecitabine—breast cancer	4.89e-05	9.74e-05	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—breast cancer	4.89e-05	9.73e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Docetaxel—breast cancer	4.88e-05	9.72e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	4.88e-05	0.000532	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—BRAF—breast cancer	4.86e-05	0.000529	CbGpPWpGaD
Ganciclovir—Confusional state—Epirubicin—breast cancer	4.85e-05	9.67e-05	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—breast cancer	4.81e-05	9.59e-05	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—breast cancer	4.81e-05	9.59e-05	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—breast cancer	4.81e-05	9.57e-05	CcSEcCtD
Ganciclovir—Infection—Epirubicin—breast cancer	4.78e-05	9.52e-05	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—breast cancer	4.76e-05	9.48e-05	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—breast cancer	4.74e-05	0.000517	CbGpPWpGaD
Ganciclovir—Convulsion—Doxorubicin—breast cancer	4.73e-05	9.42e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Capecitabine—breast cancer	4.73e-05	9.42e-05	CcSEcCtD
Ganciclovir—Dizziness—Docetaxel—breast cancer	4.72e-05	9.4e-05	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—breast cancer	4.71e-05	9.39e-05	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—breast cancer	4.71e-05	9.38e-05	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—breast cancer	4.7e-05	9.36e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—breast cancer	4.69e-05	9.33e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ALDH1A1—breast cancer	4.68e-05	0.00051	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALDH7A1—breast cancer	4.68e-05	0.00051	CbGpPWpGaD
Ganciclovir—Skin disorder—Epirubicin—breast cancer	4.68e-05	9.31e-05	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—breast cancer	4.65e-05	9.27e-05	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—breast cancer	4.65e-05	9.27e-05	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—breast cancer	4.65e-05	9.25e-05	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—breast cancer	4.65e-05	9.25e-05	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—breast cancer	4.65e-05	9.25e-05	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—breast cancer	4.63e-05	9.22e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—breast cancer	4.62e-05	9.2e-05	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.62e-05	9.19e-05	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—breast cancer	4.59e-05	9.14e-05	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—breast cancer	4.59e-05	9.14e-05	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—breast cancer	4.59e-05	9.13e-05	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—breast cancer	4.57e-05	9.11e-05	CcSEcCtD
Ganciclovir—Dizziness—Capecitabine—breast cancer	4.57e-05	9.1e-05	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—breast cancer	4.55e-05	9.05e-05	CcSEcCtD
Ganciclovir—Vomiting—Docetaxel—breast cancer	4.54e-05	9.04e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—breast cancer	4.53e-05	9.02e-05	CcSEcCtD
Ganciclovir—Rash—Docetaxel—breast cancer	4.5e-05	8.96e-05	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—breast cancer	4.5e-05	8.96e-05	CcSEcCtD
Ganciclovir—Dermatitis—Docetaxel—breast cancer	4.5e-05	8.95e-05	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—breast cancer	4.49e-05	8.94e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ADSL—breast cancer	4.49e-05	0.000489	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PHGDH—breast cancer	4.49e-05	0.000489	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UMPS—breast cancer	4.49e-05	0.000489	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NME1—breast cancer	4.49e-05	0.000489	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—FHL2—breast cancer	4.49e-05	0.000489	CbGpPWpGaD
Ganciclovir—Decreased appetite—Methotrexate—breast cancer	4.47e-05	8.91e-05	CcSEcCtD
Ganciclovir—Headache—Docetaxel—breast cancer	4.47e-05	8.9e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—NCOA1—breast cancer	4.46e-05	0.000487	CbGpPWpGaD
Ganciclovir—Oedema—Doxorubicin—breast cancer	4.46e-05	8.87e-05	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—breast cancer	4.46e-05	8.87e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—breast cancer	4.44e-05	8.84e-05	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—breast cancer	4.44e-05	8.83e-05	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—breast cancer	4.43e-05	8.81e-05	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ALB—breast cancer	4.42e-05	0.000482	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HPSE—breast cancer	4.4e-05	0.00048	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—BRIP1—breast cancer	4.4e-05	0.00048	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—LDHB—breast cancer	4.4e-05	0.00048	CbGpPWpGaD
Ganciclovir—Pain—Methotrexate—breast cancer	4.4e-05	8.76e-05	CcSEcCtD
Ganciclovir—Vomiting—Capecitabine—breast cancer	4.39e-05	8.75e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—breast cancer	4.39e-05	8.73e-05	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—breast cancer	4.36e-05	8.69e-05	CcSEcCtD
Ganciclovir—Rash—Capecitabine—breast cancer	4.36e-05	8.68e-05	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—breast cancer	4.35e-05	8.67e-05	CcSEcCtD
Ganciclovir—Dermatitis—Capecitabine—breast cancer	4.35e-05	8.67e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PLG—breast cancer	4.35e-05	0.000474	CbGpPWpGaD
Ganciclovir—Tachycardia—Doxorubicin—breast cancer	4.35e-05	8.66e-05	CcSEcCtD
Ganciclovir—Headache—Capecitabine—breast cancer	4.33e-05	8.62e-05	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—breast cancer	4.33e-05	8.62e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—breast cancer	4.32e-05	8.61e-05	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—breast cancer	4.31e-05	8.58e-05	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—breast cancer	4.29e-05	8.55e-05	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—breast cancer	4.28e-05	8.52e-05	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—breast cancer	4.25e-05	8.46e-05	CcSEcCtD
Ganciclovir—Nausea—Docetaxel—breast cancer	4.24e-05	8.44e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—breast cancer	4.24e-05	8.44e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—breast cancer	4.24e-05	8.44e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—breast cancer	4.21e-05	8.38e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—breast cancer	4.19e-05	8.33e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ABCC1—breast cancer	4.17e-05	0.000455	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA3—breast cancer	4.17e-05	0.000455	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HMMR—breast cancer	4.17e-05	0.000455	CbGpPWpGaD
Ganciclovir—Hypotension—Doxorubicin—breast cancer	4.16e-05	8.29e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—breast cancer	4.16e-05	8.28e-05	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—breast cancer	4.15e-05	8.27e-05	CcSEcCtD
Ganciclovir—Pain—Epirubicin—breast cancer	4.12e-05	8.2e-05	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—breast cancer	4.12e-05	8.2e-05	CcSEcCtD
Ganciclovir—Nausea—Capecitabine—breast cancer	4.11e-05	8.17e-05	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—breast cancer	4.09e-05	8.14e-05	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—MDM2—breast cancer	4.07e-05	0.000444	CbGpPWpGaD
Ganciclovir—Body temperature increased—Methotrexate—breast cancer	4.07e-05	8.1e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—breast cancer	4.07e-05	8.1e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.06e-05	8.08e-05	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—RAF1—breast cancer	4.05e-05	0.000442	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPARGC1B—breast cancer	4.04e-05	0.000441	CbGpPWpGaD
Ganciclovir—Insomnia—Doxorubicin—breast cancer	4.03e-05	8.02e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—HMOX1—breast cancer	4.01e-05	0.000438	CbGpPWpGaD
Ganciclovir—Paraesthesia—Doxorubicin—breast cancer	4e-05	7.97e-05	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—RAF1—breast cancer	4e-05	0.000436	CbGpPWpGaD
Ganciclovir—Dyspnoea—Doxorubicin—breast cancer	3.97e-05	7.91e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—breast cancer	3.97e-05	7.9e-05	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—breast cancer	3.96e-05	7.89e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—breast cancer	3.94e-05	7.84e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—breast cancer	3.92e-05	7.81e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—breast cancer	3.87e-05	7.71e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCB1—breast cancer	3.85e-05	0.00042	CbGpPWpGaD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—breast cancer	3.85e-05	7.66e-05	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—breast cancer	3.84e-05	7.65e-05	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—breast cancer	3.82e-05	7.62e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—GSTA4—breast cancer	3.82e-05	0.000416	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CA9—breast cancer	3.82e-05	0.000416	CbGpPWpGaD
Ganciclovir—Constipation—Doxorubicin—breast cancer	3.81e-05	7.59e-05	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—breast cancer	3.81e-05	7.59e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—breast cancer	3.81e-05	7.58e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—breast cancer	3.81e-05	7.58e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—breast cancer	3.79e-05	7.55e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—GPX2—breast cancer	3.72e-05	0.000405	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA2—breast cancer	3.72e-05	0.000405	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	3.72e-05	0.000405	CbGpPWpGaD
Ganciclovir—Asthenia—Methotrexate—breast cancer	3.69e-05	7.35e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—SULT1A1—breast cancer	3.67e-05	0.0004	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPX4—breast cancer	3.67e-05	0.0004	CbGpPWpGaD
Ganciclovir—Feeling abnormal—Doxorubicin—breast cancer	3.67e-05	7.31e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—breast cancer	3.64e-05	7.25e-05	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—breast cancer	3.64e-05	7.25e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—IDH1—breast cancer	3.59e-05	0.000391	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA1—breast cancer	3.59e-05	0.000391	CbGpPWpGaD
Ganciclovir—Hypersensitivity—Epirubicin—breast cancer	3.55e-05	7.06e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—NAT2—breast cancer	3.55e-05	0.000387	CbGpPWpGaD
Ganciclovir—Urticaria—Doxorubicin—breast cancer	3.54e-05	7.05e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—breast cancer	3.52e-05	7.01e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—breast cancer	3.52e-05	7.01e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—breast cancer	3.52e-05	7.01e-05	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—breast cancer	3.45e-05	6.88e-05	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—breast cancer	3.41e-05	6.78e-05	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—breast cancer	3.4e-05	6.77e-05	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	3.36e-05	0.000366	CbGpPWpGaD
Ganciclovir—Diarrhoea—Epirubicin—breast cancer	3.29e-05	6.56e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—breast cancer	3.28e-05	6.54e-05	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—breast cancer	3.27e-05	6.51e-05	CcSEcCtD
Ganciclovir—Rash—Methotrexate—breast cancer	3.24e-05	6.46e-05	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—breast cancer	3.24e-05	6.45e-05	CcSEcCtD
Ganciclovir—Headache—Methotrexate—breast cancer	3.22e-05	6.42e-05	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—breast cancer	3.2e-05	6.36e-05	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—breast cancer	3.18e-05	6.34e-05	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—breast cancer	3.15e-05	6.28e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—MED12—breast cancer	3.11e-05	0.000339	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—DPYD—breast cancer	3.11e-05	0.000339	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	3.1e-05	0.000338	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALDOA—breast cancer	3.06e-05	0.000334	CbGpPWpGaD
Ganciclovir—Vomiting—Epirubicin—breast cancer	3.06e-05	6.1e-05	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—breast cancer	3.06e-05	6.08e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—breast cancer	3.05e-05	6.07e-05	CcSEcCtD
Ganciclovir—Rash—Epirubicin—breast cancer	3.04e-05	6.04e-05	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—breast cancer	3.03e-05	6.04e-05	CcSEcCtD
Ganciclovir—Headache—Epirubicin—breast cancer	3.02e-05	6.01e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—NCOA3—breast cancer	2.97e-05	0.000324	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC2A2—breast cancer	2.95e-05	0.000322	CbGpPWpGaD
Ganciclovir—Dizziness—Doxorubicin—breast cancer	2.95e-05	5.87e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—HRAS—breast cancer	2.91e-05	0.000318	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCG2—breast cancer	2.89e-05	0.000315	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTR—breast cancer	2.89e-05	0.000315	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CPT1A—breast cancer	2.89e-05	0.000315	CbGpPWpGaD
Ganciclovir—Nausea—Epirubicin—breast cancer	2.86e-05	5.69e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—HPGDS—breast cancer	2.84e-05	0.000309	CbGpPWpGaD
Ganciclovir—Vomiting—Doxorubicin—breast cancer	2.83e-05	5.64e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—HBA1—breast cancer	2.82e-05	0.000307	CbGpPWpGaD
Ganciclovir—Rash—Doxorubicin—breast cancer	2.81e-05	5.59e-05	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—breast cancer	2.81e-05	5.59e-05	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	2.81e-05	0.000306	CbGpPWpGaD
Ganciclovir—Headache—Doxorubicin—breast cancer	2.79e-05	5.56e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ACHE—breast cancer	2.75e-05	0.0003	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTT1—breast cancer	2.75e-05	0.0003	CbGpPWpGaD
Ganciclovir—Nausea—Doxorubicin—breast cancer	2.65e-05	5.27e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—CYP17A1—breast cancer	2.6e-05	0.000284	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGS1—breast cancer	2.58e-05	0.000281	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ENO1—breast cancer	2.58e-05	0.000281	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2D6—breast cancer	2.53e-05	0.000276	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOA2—breast cancer	2.48e-05	0.00027	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—breast cancer	2.41e-05	0.000263	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—FASN—breast cancer	2.41e-05	0.000262	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—BCHE—breast cancer	2.4e-05	0.000261	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC5A5—breast cancer	2.37e-05	0.000258	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC2A1—breast cancer	2.29e-05	0.000249	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NQO1—breast cancer	2.29e-05	0.000249	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—HRAS—breast cancer	2.23e-05	0.000243	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP3A4—breast cancer	2.23e-05	0.000243	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP1B1—breast cancer	2.19e-05	0.000239	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	2.18e-05	0.000238	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HSP90AA1—breast cancer	2.15e-05	0.000234	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOA1—breast cancer	2.09e-05	0.000228	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—STK11—breast cancer	2.06e-05	0.000225	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP19A1—breast cancer	2.06e-05	0.000225	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—COMT—breast cancer	1.92e-05	0.000209	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTP1—breast cancer	1.91e-05	0.000208	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HMOX1—breast cancer	1.88e-05	0.000205	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ITPR1—breast cancer	1.88e-05	0.000205	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCB1—breast cancer	1.8e-05	0.000197	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TYMS—breast cancer	1.77e-05	0.000193	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTM1—breast cancer	1.75e-05	0.000191	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOR1—breast cancer	1.75e-05	0.000191	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PLA2G4A—breast cancer	1.75e-05	0.000191	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPX1—breast cancer	1.68e-05	0.000183	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP1A1—breast cancer	1.66e-05	0.000181	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ERCC2—breast cancer	1.65e-05	0.00018	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTHFR—breast cancer	1.55e-05	0.000169	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CAV1—breast cancer	1.43e-05	0.000156	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CG—breast cancer	1.3e-05	0.000142	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CD—breast cancer	1.14e-05	0.000125	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALB—breast cancer	1.13e-05	0.000123	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NOS3—breast cancer	1.08e-05	0.000118	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CB—breast cancer	9.97e-06	0.000109	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGS2—breast cancer	9.88e-06	0.000108	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTEN—breast cancer	8.61e-06	9.39e-05	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CA—breast cancer	6.08e-06	6.63e-05	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AKT1—breast cancer	4.96e-06	5.41e-05	CbGpPWpGaD
